TABLE 1
FROM:
Validation of SELDI-TOF MS serum protein profiles for renal cell carcinoma in new populations
Judith Y M N Engwegen, Niven Mehra, John B A G Haanen, Johannes M G Bonfrer, Jan H M Schellens, Emile E Voest and Jos H Beijnen
BACK TO ARTICLETable 1. Patient and sample characteristics of sample sets 1 and 2 compared to those of Won and Tolson
| Sex | Patient age (years) | RCC stage | Surgical status | Sample handling | Sample age (years) | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| RCC | HC | Non-RCC disease | RCC | HC | RCC | HC | ||||
| Set 1 | 25 M | 20 M | — | 57.1 (11.0) | 56.1 (8.79) | 16 IV | 33 presurgery | 30 min coagulation at RT | 2.94a (0.56) | 1.90 (0.034) |
| 4 III | 5 postsurgery | Centrifugation at 1900 g | ||||||||
| 15 F | 12 F | 16 I/II | 2 unknown | Storage at -30°C | ||||||
| 4 Unknown | ||||||||||
| Set 2 | 19 M | 7 M | — | 63.7b (10.2) | 42.9 (11.1) | 24 IV | 8 presurgery | 2–6 h coagulation at RT+ overnight at 4°C | 1.05 (0.55) | 1.28 (0.21) |
| 7 F | 20 F | 2 II/III | 18 postsurgery | Centrifugation at 1500 g | ||||||
| Storage at -80°C | ||||||||||
| Tolson | 15 M | 26 matched | — | 59.3 (14.6) | Matched | 1 III | 25 presurgery | Serum supernatant collected | NR | NR |
| 10 F | 6 IV | Overnight coagulation at 4°C | ||||||||
| 7 II | Storage at -70°C | |||||||||
| 11 I | ||||||||||
| Won | 15 M+F | 6 M+F | 15 M+F | NR | NR | NR | 15 presurgery | NR | All collected in same period | |
Means (s.d.) for patient and sample age.
Abbreviations: F: female, HC: healthy control, M: male, NR: not reported, RCC: renal cell carcinoma, RT: room temperature.
a P<0.000 independent samples t-test.
b P<0.000 nonparametric Mann–Whitney U-test.
